Professor Irit Bahar is the Head of the Ophthalmology Department at Rabin Medical Center and a leading expert in cornea, external eye disease, and refractive surgery.
She earned her medical degree from the Technion – Israel Institute of Technology and completed her ophthalmology residency at Rabin Medical Center, followed by a prestigious fellowship in cornea and refractive surgery at Toronto Western Hospital in Canada.

A dedicated clinician-scientist, Prof. Bahar has published extensively in peer-reviewed journals and contributed to several book chapters in the field of ophthalmology. Her clinical and research interests include advanced corneal transplantation techniques, artificial corneas, corneal neovascularization, and stem cell deficiency. She has received numerous national and international awards for clinical excellence and scientific achievement.

Prof. Bahar is deeply committed to medical education, mentoring medical students and ophthalmology residents. She serves as a reviewer and editorial board member for leading international ophthalmology journals.

Dr. Alon Zahavi is an ophthalmologist specializing in glaucoma and cataract surgery. He earned his medical degree from the Hebrew University of Jerusalem and completed his ophthalmology residency at Rabin Medical Center. He later pursued advanced fellowship training in glaucoma at Sydney Eye Hospital in Australia and completed an observership at Columbia University Medical Center in New York. 

Dr. Zahavi serves as a senior glaucoma and cataract surgeon at Rabin Medical Center. As a senior lecturer at Tel Aviv University, he is deeply involved in medical education, teaching and mentoring medical students, ophthalmology residents, and graduate research students. 

As Head of the Eye Research Laboratory at the Felsenstein Medical Research Center, Dr. Zahavi leads multidisciplinary projects exploring ocular pathologies with a focus on glaucoma, neurodegeneration, inflammation, and novel therapeutic approaches. His research integrates animal models, molecular biology, imaging, and translational methodologies. He has received several competitive research grants, including support from the Israeli Ministry of Health and Tel Aviv University.

Dr. Zahavi has authored numerous peer-reviewed scientific publications and book chapters and frequently presents his work at national and international conferences. He serves on the editorial boards of leading ophthalmology journals and is a member of the Helsinki Ethics Committee, the Animal Research Ethics Committee, and the Clalit Health Services Multicenter Ethics Review Board, where he contributes to the oversight of clinical and preclinical research in Israel. 

Yael is a senior lab scientist and a founding member of the Eye Research Lab.
She holds an M.Sc. in Biology from the Hebrew University of Jerusalem, with a specialization in cell and animal sciences. Yael brings extensive expertise in animal models, tissue culture, advanced microscopy, and a wide array of laboratory techniques that support cutting-edge ophthalmic research. She has been a key contributor to numerous studies on retinal, corneal, and optic nerve pathologies, and actively collaborates on projects aimed at developing innovative treatments for various eye diseases. Her work spans both basic research and translational studies, contributing to the advancement of novel therapeutic strategies. 

Prof. Tami Livnat is the Head of the Amalia Biron Thrombosis Research Institute at Tel Aviv University and Sheba Medical Center.
As part of an ongoing collaboration with the Laboratory of Eye Research at the Felsenstein Medical Research Center, her group is exploring the therapeutic potential of the natural anticoagulant activated protein C (APC) and its analogs for the treatment of inflammatory, angiogenic, and neurodegenerative eye diseases.

Prof. Michal Kramer, MD. Head of uveitis service at Rabin Medical Center; including pediatric uveitis clinic at Schneider children’s medical center of Israel. Clinical associate professor at The School of Medicine, Tel Aviv University, Tel Aviv.

Graduated at Hadassah Medical School, Hebrew university, Jerusalem; Residency in the Department of Ophthalmology, Rabin Medical Center; Research fellowship in retinal diseases at MEEI, Boston USA, and training in Uveitis at Moorfields Eye Hospital, London UK.  Co-founder of the Israeli Uveitis Society, and its first chair-person (2009-2014).  

Prof. Michal Kramer, is an active member in the IUSG; IOIS; AUS; and participated in the  SUN working Group. Research interests includes epigenetic changes in uveitis patients, multimodal imaging  incorporating AI technology,  cannabinoid system in a murine experimental uveitis model, and clinical research in uveitis.

Prof. Michal Kramer serves as the current chair of the Israeli Society of Vision and Eye Research (ISVER).

Prof. Livny Heads the Cornea Unit and serves as a senior physician and surgeon at the Department of Ophthalmology at Rabin Medical Center.
He specializes in corneal diseases, corneal transplantation, laser vision correction, and cataract surgery.
Prof. Livny's research focuses on corneal graft processing, corneal neovascularization, and techniques for vision improvement in corneal pathologies. 

Dr. Assaf Dotan is the head of the retina unit at the Ophthalmology department in the Rabin Medical Center and holds an academic position of a lecturer at the faculty of medicine, Tel-Aviv University.

He completed his residency period in Ophthalmology in 2014 at the Rabin Medical Center in Petah-Tiqva, which was followed by a clinical comprehensive vitreo-retinal fellowship at the University of Alberta, in Edmonton, Canada.

Dr. Dotan has authored numerous peer-reviewed scientific publications in high-impact ophthalmology journals. His work has been supported by competitive grants from the Maratier Fund for Innovative Research, the Rabin Medical Center Researchers program, and the Scientific Council of the Israeli Medical Association.

He has successfully mentored MD and MSc students in both basic science and translational ophthalmology research, in collaboration with Felsenstein Medical Research Center and the Department of Ophthalmology at Rabin Medical Center. Dr. Dotan has presented his findings extensively at international conferences such as ARVO, ASRS, EURETINA, and the American Academy of Ophthalmology.

His current research interests include the clearance dynamics of anti-VEGF agents in ocular tissues, experimental models for retinal detachment repair, and new strategies for improving outcomes in complex vitreoretinal surgeries.

Dr. Yariv Keshet, MD is a board-certified vitreoretinal surgeon and ophthalmologist with comprehensive training in clinical and surgical retina, medical innovation, and translational research.
He completed fellowships at the Vitreous-Retina-Macula Consultants of New York under Dr. Richard F. Spaide and at the University of Toronto, with a focus on complex retinal diseases and advanced imaging.
Dr. Keshet’s research spans retinal pharmacokinetics, imaging biomarkers, and novel surgical techniques, with numerous peer-reviewed publications and international conference presentations. He is currently affiliated with Beilinson Hospital, the Mor Institute, and Medica Medical Center, combining clinical excellence with active contributions to retinal science.

Dr. Ben-Arzi is a vitreoretinal fellow at Rabin Medical Center. His research investigates intravitreal injections of anti-vascular endothelial growth factor (VEGF) agents in a choroidal neovascularization animal model for studying the pathophysiological mechanism of sustained elevated intraocular pressure (IOP), using techniques of immunohistochemistry processing and molecular biology.